JP Morgan Chase
IBB icon

JP Morgan Chase’s iShares Biotechnology ETF IBB Stock Holding History

JP Morgan Chase’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120M Sell
630,190
-1,830,764
-74% -$315M 0.01% 977
2026
Q1 		$398M Buy
2,460,954
+2,112,897
+607% +$361M 0.03% 472
2025
Q4 		$58.7M Sell
348,057
-711,991
-67% -$116M ﹤0.01% 1257
2025
Q3 		$153M Buy
1,060,048
+226,852
+27% +$31M 0.01% 807
2025
Q2 		$105M Buy
833,196
+355,000
+74% +$43.6M 0.01% 912
2025
Q1 		$61.2M Buy
478,196
+163,798
+52% +$22.2M ﹤0.01% 1201
2024
Q4 		$41.6M Sell
314,398
-256,444
-45% -$36.1M ﹤0.01% 1443
2024
Q3 		$83.1M Sell
570,842
-1,436,790
-72% -$208M 0.01% 1038
2024
Q2 		$276M Buy
2,007,632
+398,907
+25% +$53.3M 0.02% 527
2024
Q1 		$221M Sell
1,608,725
-418,820
-21% -$57.2M 0.02% 620
2023
Q4 		$275M Buy
2,027,545
+184,720
+10% +$22.5M 0.03% 523
2023
Q3 		$225M Sell
1,842,825
-195,131
-10% -$24.8M 0.02% 521
2023
Q2 		$259M Buy
2,037,956
+71,597
+4% +$9.3M 0.03% 487
2023
Q1 		$254M Buy
1,966,359
+1,209,700
+160% +$158M 0.03% 470
2022
Q4 		$99.3M Buy
756,659
+283,756
+60% +$36.7M 0.01% 773
2022
Q3 		$55.3M Buy
472,903
+64,830
+16% +$8.05M 0.01% 1003
2022
Q2 		$48M Sell
408,073
-218,793
-35% -$26M 0.01% 1059
2022
Q1 		$81.7M Buy
626,866
+142,937
+30% +$18.6M 0.01% 932
2021
Q4 		$73.9M Sell
483,929
-1,192,810
-71% -$185M 0.01% 1015
2021
Q3 		$271M Buy
1,676,739
+249,296
+17% +$42M 0.03% 487
2021
Q2 		$234M Sell
1,427,443
-636,315
-31% -$98M 0.03% 554
2021
Q1 		$311M Buy
2,063,758
+1,475,419
+251% +$234M 0.04% 443
2020
Q4 		$89.1M Sell
588,339
-1,571,927
-73% -$225M 0.01% 818
2020
Q3 		$291M Sell
2,160,266
-834,510
-28% -$113M 0.05% 371
2020
Q2 		$409M Buy
2,994,776
+1,590,525
+113% +$203M 0.08% 255
2020
Q1 		$151M Buy
1,404,251
+1,231,166
+711% +$142M 0.04% 453
2019
Q4 		$20.9M Sell
173,085
-1,615,038
-90% -$180M ﹤0.01% 1562
2019
Q3 		$178M Buy
1,788,123
+680,054
+61% +$71.2M 0.04% 472
2019
Q2 		$119M Buy
1,108,069
+604,388
+120% +$64.3M 0.02% 616
2019
Q1 		$56.3M Sell
503,681
-613,927
-55% -$67.3M 0.01% 893
2018
Q4 		$108M Buy
1,117,608
+609,822
+120% +$64.7M 0.02% 599
2018
Q3 		$61.9M Sell
507,786
-101,598
-17% -$12M 0.01% 914
2018
Q2 		$66.9M Buy
609,384
+144,916
+31% +$15.5M 0.01% 833
2018
Q1 		$49.6M Buy
464,468
+30,909
+7% +$3.43M 0.01% 940
2017
Q4 		$46.3M Sell
433,559
-661,033
-60% -$70.7M 0.01% 1026
2017
Q3 		$121M Sell
1,094,592
-82,764
-7% -$8.85M 0.03% 552
2017
Q2 		$122M Sell
1,177,356
-1,169,181
-50% -$115M 0.03% 549
2017
Q1 		$229M Buy
2,346,537
+736,374
+46% +$70.5M 0.05% 366
2016
Q4 		$142M Buy
1,610,163
+46,884
+3% +$4.27M 0.03% 476
2016
Q3 		$151M Sell
1,563,279
-64,908
-4% -$6.17M 0.04% 441
2016
Q2 		$140M Buy
1,628,187
+1,516,428
+1,357% +$136M 0.03% 466
2016
Q1 		$9.71M Sell
111,759
-2,035,371
-95% -$182M ﹤0.01% 1795
2015
Q4 		$242M Sell
2,147,130
-1,162,335
-35% -$126M 0.06% 331
2015
Q3 		$335M Sell
3,309,465
-849,924
-20% -$102M 0.09% 252
2015
Q2 		$512M Sell
4,159,389
-501,480
-11% -$60M 0.12% 187
2015
Q1 		$534M Buy
4,660,869
+1,803,627
+63% +$199M 0.12% 188
2014
Q4 		$289M Sell
2,857,242
-895,893
-24% -$87.1M 0.07% 336
2014
Q3 		$342M Buy
3,753,135
+3,192,564
+570% +$280M 0.08% 274
2014
Q2 		$48M Sell
560,571
-47,163
-8% -$3.72M 0.01% 869
2014
Q1 		$47.9M Sell
607,734
-87,351
-13% -$7.28M 0.01% 835
2013
Q4 		$52.6M Sell
695,085
-3,519
-0.5% -$250K 0.01% 779
2013
Q3 		$48.8M Sell
698,604
-242,379
-26% -$15.9M 0.01% 803
2013
Q2 		$54.5M Buy
+940,983
New +$54.4M 0.02% 724

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

JP Morgan Chase's IBB Position: Q2 2026 in Review

JP Morgan Chase reduced its iShares Biotechnology ETF (IBB) stake by 74% in Q2 2026, selling an estimated $315M and leaving 630,190 shares worth $120M. The position accounts for 0.01% of the portfolio, ranked #977.

JP Morgan Chase first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $534M in Q1 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • JP Morgan Chase held 630,190 shares of iShares Biotechnology ETF worth $120M as of Q2 2026.
  • JP Morgan Chase sold 1,830,764 iShares Biotechnology ETF shares in Q2 2026, an estimated $315M.
  • iShares Biotechnology ETF made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #977 holding.
  • JP Morgan Chase first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's iShares Biotechnology ETF position peaked at $534M in Q1 2015.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.